| Bridget Rose Davidson, CNM | |
|
5140 N California Ave, Ste 635, Chicago, IL 60625-3645 | |
| (773) 989-6200 | |
| Not Available |
| Full Name | Bridget Rose Davidson |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 5140 N California Ave, Chicago, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285990911 | NPI | - | NPPES |
| 041384723 | Medicaid | IL | |
| 406120066 | Other | PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 209009174 (Illinois) | Primary |
| Entity Name | The University Of Chicago Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033218128 PECOS PAC ID: 7618880766 Enrollment ID: O20031113000198 |
News Archive
With an increase in the elderly and aging population and also in the number of invasive surgeries, wound healing has become a critical focus area in medicine.
Researchers at Queen's University have identified a new mechanism that could potentially explain why the body's immune system sometimes fails to eliminate cancer. The new findings shed light on the possible cause of immune resistance in cancer cells, and indicate that nitroglycerin, a relatively safe and low-cost drug used for more than a century to treat angina, may be effective for managing certain cancers.
Acorda Therapeutics, Inc. today announced that AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg is now available by prescription in the United States and Puerto Rico. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is indicated for use in all types of MS, and can be used either alone or with existing therapies, including disease-modifying agents.
Today, the U.S. Food and Drug Administration permitted marketing of the PicoAMH Elisa diagnostic test as an aid in the determination of a patient's menopausal status.
› Verified 8 days ago
| Entity Name | Swedish Covenant Management Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760432348 PECOS PAC ID: 4486556016 Enrollment ID: O20040123000850 |
News Archive
With an increase in the elderly and aging population and also in the number of invasive surgeries, wound healing has become a critical focus area in medicine.
Researchers at Queen's University have identified a new mechanism that could potentially explain why the body's immune system sometimes fails to eliminate cancer. The new findings shed light on the possible cause of immune resistance in cancer cells, and indicate that nitroglycerin, a relatively safe and low-cost drug used for more than a century to treat angina, may be effective for managing certain cancers.
Acorda Therapeutics, Inc. today announced that AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg is now available by prescription in the United States and Puerto Rico. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is indicated for use in all types of MS, and can be used either alone or with existing therapies, including disease-modifying agents.
Today, the U.S. Food and Drug Administration permitted marketing of the PicoAMH Elisa diagnostic test as an aid in the determination of a patient's menopausal status.
› Verified 8 days ago
| Entity Name | Northshore University Healthsystem Faculty Practice Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497701882 PECOS PAC ID: 2163334699 Enrollment ID: O20040524000118 |
News Archive
With an increase in the elderly and aging population and also in the number of invasive surgeries, wound healing has become a critical focus area in medicine.
Researchers at Queen's University have identified a new mechanism that could potentially explain why the body's immune system sometimes fails to eliminate cancer. The new findings shed light on the possible cause of immune resistance in cancer cells, and indicate that nitroglycerin, a relatively safe and low-cost drug used for more than a century to treat angina, may be effective for managing certain cancers.
Acorda Therapeutics, Inc. today announced that AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg is now available by prescription in the United States and Puerto Rico. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is indicated for use in all types of MS, and can be used either alone or with existing therapies, including disease-modifying agents.
Today, the U.S. Food and Drug Administration permitted marketing of the PicoAMH Elisa diagnostic test as an aid in the determination of a patient's menopausal status.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bridget Rose Davidson, CNM 2740 W Foster Ave, Ll7, Chicago, IL 60625-3500 Ph: (773) 878-8200 | Bridget Rose Davidson, CNM 5140 N California Ave, Ste 635, Chicago, IL 60625-3645 Ph: (773) 989-6200 |
News Archive
With an increase in the elderly and aging population and also in the number of invasive surgeries, wound healing has become a critical focus area in medicine.
Researchers at Queen's University have identified a new mechanism that could potentially explain why the body's immune system sometimes fails to eliminate cancer. The new findings shed light on the possible cause of immune resistance in cancer cells, and indicate that nitroglycerin, a relatively safe and low-cost drug used for more than a century to treat angina, may be effective for managing certain cancers.
Acorda Therapeutics, Inc. today announced that AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg is now available by prescription in the United States and Puerto Rico. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is indicated for use in all types of MS, and can be used either alone or with existing therapies, including disease-modifying agents.
Today, the U.S. Food and Drug Administration permitted marketing of the PicoAMH Elisa diagnostic test as an aid in the determination of a patient's menopausal status.
› Verified 8 days ago
Jacqueline S Ma, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 966 W 21st St, Chicago, IL 60608 Phone: 773-254-1400 Fax: 312-829-6375 | |
Tracy A Abraham, Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1220 S Wood St, Chicago, IL 60608 Phone: 312-996-2000 Fax: 312-413-2026 | |
Christina Volkening, MSN, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 2233 W Division St, Chicago, IL 60622 Phone: 312-770-2000 | |
Mallory Marie Klocke, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1117 W Lunt Ave Apt 2a, Chicago, IL 60626 Phone: 712-210-2717 | |
Rebecca Etrenne, APN Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 219 W Chicago Ave, Chicago, IL 60654 Phone: 312-878-1945 | |
Ms. Alyssa Suzanne Mull, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1701 W Superior Street, Erie Family Health Center, Chicago, IL 60622 Phone: 312-666-3494 | |
Kamila Stoksik, DNP Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 250 E Superior St, Chicago, IL 60611 Phone: 312-472-2900 |